Polaryx Therapeutics PLYX
NASDAQ PLYX
$1.94 +0.03 (+1.57%)
At close: Oct 21, 2026 · 4:00 PM EDT

Polaryx Therapeutics (PLYX) Research & Development (2025 - 2026)

Updated

Polaryx Therapeutics' Research & Development came in at $719,000 for Q2 2026, up 51.1% from $476,000 a year earlier and up 5.9% from the prior quarter.

Analysis

Polaryx Therapeutics (PLYX) Research & Development (2025 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Polaryx Therapeutics reported Research & Development of $6.59 million; for FY2025, it came in at $6.27 million, up 122.9% from FY2024.

  • Going back by year, Research & Development was $2.81 million in FY2024.
  • The Q2 2026 figure represents the highest quarterly Research & Development since Q1 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Eli Lilly 1,176.80 Bn 1,145.39 Bn 19.71 Bn 3.82 Bn
2 Johnson & Johnson 639.81 Bn 558.34 Bn 17.26 Bn 3.65 Bn
3 AbbVie 503.28 Bn 476.39 Bn 12.70 Bn 2.34 Bn
4 Merck 376.70 Bn 331.08 Bn 12.21 Bn 9.74 Bn
5 Novartis Ag 303.61 Bn 267.60 Bn 11.24 Bn 2.85 Bn
6 Astrazeneca 268.37 Bn 242.05 Bn 12.86 Bn 4.05 Bn
7 Amgen 242.34 Bn 197.74 Bn 7.24 Bn 1.87 Bn
8 Gilead Sciences 193.58 Bn 167.78 Bn 6.22 Bn 1.76 Bn
9 Pfizer 172.88 Bn 119.53 Bn 10.94 Bn 2.81 Bn
10 Polaryx Therapeutics 95.21 Mn 70.82 Mn - 719,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 719,000.00
Mar 31, 2026 679,000.00
Jun 30, 2025 476,000.00
Mar 31, 2025 4.72 Mn
API Access

Polaryx Therapeutics Research & Development API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=research-and-development&ticker=PLYX&period=max&api_key=YOUR_API_KEY